
### [MONDO:0008394](http://purl.obolibrary.org/obo/MONDO_0008394)
**Label:** Silver-Russell syndrome

**Subclasses:** [MONDO:0010727](http://purl.obolibrary.org/obo/MONDO_0010727) (Russell-silver syndrome, X-linked), [MONDO:0014663](http://purl.obolibrary.org/obo/MONDO_0014663) (growth restriction, severe, with distinctive facies), [MONDO:0018336](http://purl.obolibrary.org/obo/MONDO_0018336) (silver-Russell syndrome due to a point mutation), [MONDO:0016479](http://purl.obolibrary.org/obo/MONDO_0016479) (silver-Russell syndrome due to 7p11.2p13 microduplication), [MONDO:0016481](http://purl.obolibrary.org/obo/MONDO_0016481) (silver-Russell syndrome due to 11p15 microduplication), [MONDO:0016480](http://purl.obolibrary.org/obo/MONDO_0016480) (silver-Russell syndrome due to an imprinting defect of 11p15), [MONDO:0016482](http://purl.obolibrary.org/obo/MONDO_0016482) (silver-Russell syndrome due to maternal uniparental disomy of chromosome 11), [MONDO:0019913](http://purl.obolibrary.org/obo/MONDO_0019913) (silver-Russell syndrome due to maternal uniparental disomy of chromosome 7), 

**Mapped go classes:** [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0045725](http://purl.obolibrary.org/obo/GO_0045725) (positive regulation of glycogen biosynthetic process), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0009749](http://purl.obolibrary.org/obo/GO_0009749) (response to glucose), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0038028](http://purl.obolibrary.org/obo/GO_0038028) (insulin receptor signaling pathway via phosphatidylinositol 3-kinase), [GO:0046628](http://purl.obolibrary.org/obo/GO_0046628) (positive regulation of insulin receptor signaling pathway), [GO:2000252](http://purl.obolibrary.org/obo/GO_2000252) (negative regulation of feeding behavior), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0042104](http://purl.obolibrary.org/obo/GO_0042104) (positive regulation of activated T cell proliferation), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0043085](http://purl.obolibrary.org/obo/GO_0043085) (positive regulation of catalytic activity), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0031667](http://purl.obolibrary.org/obo/GO_0031667) (response to nutrient levels), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0060669](http://purl.obolibrary.org/obo/GO_0060669) (embryonic placenta morphogenesis), [GO:0048018](http://purl.obolibrary.org/obo/GO_0048018) (receptor ligand activity), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0001892](http://purl.obolibrary.org/obo/GO_0001892) (embryonic placenta development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0051147](http://purl.obolibrary.org/obo/GO_0051147) (regulation of muscle cell differentiation), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0051781](http://purl.obolibrary.org/obo/GO_0051781) (positive regulation of cell division), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0031056](http://purl.obolibrary.org/obo/GO_0031056) (regulation of histone modification), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0043539](http://purl.obolibrary.org/obo/GO_0043539) (protein serine/threonine kinase activator activity), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0035094](http://purl.obolibrary.org/obo/GO_0035094) (response to nicotine), [GO:0045953](http://purl.obolibrary.org/obo/GO_0045953) (negative regulation of natural killer cell mediated cytotoxicity), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:2000228](http://purl.obolibrary.org/obo/GO_2000228) (positive regulation of pancreatic A cell differentiation), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:2000467](http://purl.obolibrary.org/obo/GO_2000467) (positive regulation of glycogen (starch) synthase activity), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [GO:2000467](http://purl.obolibrary.org/obo/GO_2000467) (positive regulation of glycogen (starch) synthase activity) 52.27%
- [GO:2000465](http://purl.obolibrary.org/obo/GO_2000465) (regulation of glycogen (starch) synthase activity) 52.27%
- [GO:0060669](http://purl.obolibrary.org/obo/GO_0060669) (embryonic placenta morphogenesis) 52.27%
- [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development) 52.27%
- [GO:0042104](http://purl.obolibrary.org/obo/GO_0042104) (positive regulation of activated T cell proliferation) 52.27%
- [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth) 52.27%
- [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration) 52.27%
- [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development) 52.27%
- [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development) 52.27%
- [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development) 52.27%
- [GO:0009792](http://purl.obolibrary.org/obo/GO_0009792) (embryo development ending in birth or egg hatching) 52.27%
- [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development) 52.27%
- [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development) 52.27%
- [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation) 52.27%


